Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$6.3 - $8.95 $1.29 Million - $1.83 Million
-204,107 Reduced 61.98%
125,205 $1.02 Million
Q1 2024

May 15, 2024

BUY
$5.26 - $10.15 $1.28 Million - $2.47 Million
243,400 Added 283.31%
329,312 $2.66 Million
Q4 2023

Feb 14, 2024

SELL
$4.21 - $6.32 $180,541 - $271,026
-42,884 Reduced 33.3%
85,912 $471,000
Q3 2023

Nov 14, 2023

SELL
$5.14 - $11.28 $929,779 - $2.04 Million
-180,891 Reduced 58.41%
128,796 $672,000
Q2 2023

Aug 14, 2023

BUY
$10.01 - $13.86 $3.1 Million - $4.29 Million
309,687 New
309,687 $3.58 Million
Q2 2021

Aug 13, 2021

BUY
$52.03 - $68.77 $648,970 - $857,768
12,473 New
12,473 $813,000
Q1 2021

May 17, 2021

SELL
$43.96 - $55.99 $414,806 - $528,321
-9,436 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$27.19 - $44.68 $1.99 Million - $3.27 Million
-73,271 Reduced 88.59%
9,436 $422,000
Q3 2020

Nov 16, 2020

BUY
$27.01 - $37.31 $2.23 Million - $3.09 Million
82,707 New
82,707 $2.4 Million
Q1 2020

May 15, 2020

SELL
$32.63 - $67.59 $15,564 - $32,240
-477 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$45.95 - $76.15 $2.92 Million - $4.83 Million
-63,486 Reduced 99.25%
477 $33,000
Q3 2019

Nov 14, 2019

BUY
$41.82 - $66.71 $656,072 - $1.05 Million
15,688 Added 32.5%
63,963 $3.07 Million
Q2 2019

Aug 14, 2019

SELL
$63.19 - $95.15 $461,602 - $695,070
-7,305 Reduced 13.14%
48,275 $3.22 Million
Q1 2019

May 14, 2019

BUY
$90.12 - $152.23 $3.22 Million - $5.44 Million
35,747 Added 180.24%
55,580 $5.3 Million
Q4 2018

Feb 14, 2019

BUY
$112.83 - $239.74 $2.24 Million - $4.75 Million
19,833 New
19,833 $2.46 Million
Q2 2018

Aug 14, 2018

SELL
$123.8 - $192.48 $480,096 - $746,437
-3,878 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$114.22 - $133.22 $442,945 - $516,627
3,878 New
3,878 $476,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $218M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.